BridgeMD
New treatment option for Speech Sound Disorder
Official title AI-Assisted Treatment for Residual Speech Sound Disorders
ClinicalTrials.gov ID: NCT05988515
What this study is testing
- What it's testing
- The goal of this randomized-controlled trial is to determine how artificial intelligence-assisted home practice may enhance speech learning of the "r" sound in school-age children with residual speech sound disorders. All child participants will receive 1 speech lesson per week, via telepractice, for 5 weeks with a human speech-language clinician.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 9 to 17. Healthy volunteers may be eligible.
You may be able to join if
- Must speak a rhotic dialect of American English as a dominant language.
- Must have begun learning English by at least the age of 3 years.
- Must be between 9;0 to 17;11 years of age.
- Must have reported difficulty with /ɹ/ production.
- Must have reported hearing within normal limits.
You likely can't join if
- Must have no known history of autism spectrum disorder, Down Syndrome, cerebral palsy, intellectual disability, permanent hearing loss...
- Must not have diagnosis of attention deficit disorder, attention deficit hyperactivity disorder, Tourette's, or Obsessive-compulsive disorder.
- Must have no orthodontic appliances that block the roof of the mouth (e.g., palate expanders).
- Must not have current cleft palate, fluency disorder, or voice disorder.
- Must not demonstrate childhood apraxia of speech (CAS-only) features in BOTH articulatory and rate/prosody domains of the ProCAD.
See the full eligibility criteria
- Must speak a rhotic dialect of American English as a dominant language.
- Must have begun learning English by at least the age of 3 years.
- Must be between 9;0 to 17;11 years of age.
- Must have reported difficulty with /ɹ/ production.
- Must have reported hearing within normal limits.
- Must receive a Scaled Score of 5 or above on both the Listening Comprehension and Story Retelling subtests from the Test of Integrated Language \& Literacy Skills (TILLS).
- Must receive a percentile score of 8 or below on the Goldman-Fristoe Test of Articulation-3 (GFTA-3) Sounds in Words subtest.
- Must have 1 scorable response with 5+ consecutive correct /pataka/ with \> 3.4 syllables per second in the MRR-Tri task of the Maximum Performance Tasks OR must demonstrate no childhood apraxia of speech (CAS-only)...
- Must score \<40% accurate based on word-level items from our /ɹ/ probe list.
- Must score \>=15% accuracy on /ɹ/ on 45 syllables following Dynamic Assessment.
- Must express interest in changing their /ɹ/ production.
- Must have oral structure and function that are appropriate for /ɹ/ production.
- Must have access to broadband internet with videoconferencing capabilities
- Must have no known history of autism spectrum disorder, Down Syndrome, cerebral palsy, intellectual disability, permanent hearing loss, epilepsy/antiepileptic medication, or brain injury/neurosurgery/stroke.
- Must not have diagnosis of attention deficit disorder, attention deficit hyperactivity disorder, Tourette's, or Obsessive-compulsive disorder.
- Must have no orthodontic appliances that block the roof of the mouth (e.g., palate expanders).
- Must not have current cleft palate, fluency disorder, or voice disorder.
- Must not demonstrate childhood apraxia of speech (CAS-only) features in BOTH articulatory and rate/prosody domains of the ProCAD.
The study team makes the final eligibility decision.
Where it's taking place
- Syracuse, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 9 years to 17 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Syracuse, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.